Australia - inglés - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - pizotifen malate, quantity: 0.725 mg - tablet, sugar coated - excipient ingredients: colloidal anhydrous silica; povidone; acacia; purified talc; sucrose; lactose monohydrate; cetyl palmitate; magnesium stearate; maize starch; titanium dioxide - indications as at 14 june 2004: prophylactic (interval) treatment of vascular headaches: typical and atypical migraine, vasomotor headache, cluster headache (horton's syndrome). sandomigran is without effect in the migraine attack. for this purpose preparations containing ergotamine are recommended.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - pizotifen malate 0.725mg equivalent to 0.5 mg pizotifen;  ;   - tablet - 500 mcg - active: pizotifen malate 0.725mg equivalent to 0.5 mg pizotifen     excipient: acacia cetyl palmitate colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch povidone purified talc   sucrose titanium dioxide - indications prophylactic treatment of recurrent vascular headaches, such as · typical or atypical migraine · vasomotor headache · cluster headache (horton's syndrome). sandomigran is less effective in tension headache and in psychogenic and post-traumatic headaches. it is not effective in relieving migraine attacks once in progress.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - pizotifen 1mg - tablet - 1 mg - active: pizotifen 1mg

Australia - inglés - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - pizotifen malate -

Canadá - inglés - Health Canada

paladin labs inc. - pizotifen (pizotifen malate) - tablet - 1mg - pizotifen (pizotifen malate) 1mg - antimigraine agents, miscellaneous

Canadá - inglés - Health Canada

paladin labs inc. - pizotifen (pizotifen malate) - tablet - 0.50mg - pizotifen (pizotifen malate) 0.50mg - antimigraine agents, miscellaneous

Nigeria - inglés - NAFDAC (National Agency for Food and Drugs Administration and Control)

pizotifen 500mg

Zimbabue - inglés - Medicines Control Authority

novartis pharmaceutical corporation - pizotifen malate - tablet, coated; oral - 0.5mg

Sudáfrica - inglés - South African Health Products Regulatory Authority (SAHPRA)

novartis south africa (pty) ltd - tablet - each tablet contains pizotifen hydrogen maleate equivalent to 0,5 mg pizotifen

Namibia - inglés - Namibia Medicines Regulatory Council

novartis south africa (pty) ltd - pizotifen hydrogen maleate as pizotifen base 0.5mg - tablet - 0.5mg pizotifen /tablet